Provided by Tiger Trade Technology Pte. Ltd.

SIMCERE PHARMA

12.150
+0.0200.16%
Volume:6.74M
Turnover:81.39M
Market Cap:31.54B
PE:41.64
High:12.240
Open:12.060
Low:11.900
Close:12.130
52wk High:15.080
52wk Low:6.099
Shares:2.60B
HK Float Shares:2.60B
Volume Ratio:1.25
T/O Rate:0.26%
Dividend:0.17
Dividend Rate:1.44%
EPS(LYR):0.292
ROE:12.45%
ROA:6.50%
PB:3.90
PE(LYR):41.64
PS:3.97

Loading ...

Hong Kong Market Kicks Off November with Gains in Traditional Sectors; Rotation Strategy Emerges

Stock News
·
Nov 03, 2025

Simcere Pharmaceutical Group Limited (2096) Announces Further Revision of 2025 and 2026 Annual Caps

Bulletin Express
·
Oct 20, 2025

Simcere Pharmaceutical Revises 2025 and 2026 Annual Caps for Exclusive Promotion Services Agreement

Reuters
·
Oct 20, 2025

Evaluating Simcere Pharmaceutical Group (SEHK:2096) Valuation After First U.S. Patient Dosed in Oncology Trial

Simply Wall St.
·
Oct 19, 2025

Hong Kong Stocks Movement: SIMCERE PHARMA (02096) Rises Over 4% as First U.S. Patient Enrolled in Phase I Trial of Novel ADC Candidate SIM0505

Stock News
·
Oct 17, 2025

BRIEF-NextCure And Simcere Zaiming Announce Expansion Of Ongoing Phase 1 Trial Of SIM0505 Into The US

Reuters
·
Oct 16, 2025

NextCure and Simcere Zaiming Announce Expansion of Ongoing Phase 1 Trial of Sim0505 (Cdh6 ADC) Into the United States

THOMSON REUTERS
·
Oct 16, 2025

NextCure Inc - Trial to Accelerate Proof-of-Concept Data in 1H 2026

THOMSON REUTERS
·
Oct 16, 2025

Chinese Pharmaceutical Stocks Drop as Investors Take Profit -- Market Talk

Dow Jones
·
Oct 09, 2025

Simcere Pharmaceutical Group Ltd. Reports 15.1% Rise in Revenue to RMB3,585 Million for H1 2025; Innovative Pharmaceutical Business Revenue Up 26%

Reuters
·
Sep 29, 2025

BOCOM International: Trump's Drug Tariffs Have Limited Impact on Chinese Pharmaceuticals, Recommends Focus on AKESO (09926) and Others

Stock News
·
Sep 29, 2025

Nearly Half of Chinese Adults Struggle with Sleep Issues as Pharmaceutical Companies Race to Develop Next-Generation Insomnia Medications

Stock News
·
Sep 22, 2025

Simcere Pharmaceutical Group (SEHK:2096) Completes HK$2 Billion Follow-On Equity Offering

Simply Wall St.
·
Sep 12, 2025

SIMCERE PHARMA (02096) Completes Placement of Existing Shares and Subscription of New Shares Under General Mandate with "Top-up" Arrangement

Stock News
·
Sep 10, 2025

Simcere Pharmaceutical Group Ltd. Completes Placing of Existing Shares and Top-Up Subscription of New Shares

Reuters
·
Sep 10, 2025

From "Import" to "Local Production": SIMCERE PHARMA (02096) Leverages Free Trade Port Policies to Build Comprehensive Innovation Drug Industry Chain

Stock News
·
Sep 10, 2025

BRIEF-Simcere Pharmaceutical Group Says SIM0609 Obtains Clinical Trial Approval In China By NMPA

Reuters
·
Sep 08, 2025

Simcere Pharma Gets China Nod for Tumor Drug Trial

MT Newswires Live
·
Sep 08, 2025

SIMCERE PHARMA (02096): SIM0609 (CDH17 Antibody-Drug Conjugate) Receives Clinical Trial Approval from National Medical Products Administration

Stock News
·
Sep 08, 2025

Simcere Pharmaceutical Group Announces Clinical Trial Approval for Innovative Anti-Tumor Drug SIM0609

Reuters
·
Sep 08, 2025